Literature DB >> 19564705

Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.

Akihiro Sakurai1, Akiko Murakami, Kenji Sano, Shinya Uchino, Yoshimitsu Fukushima.   

Abstract

Neuroendocrine tumors develop in various organs in patients with multiple endocrine neoplasia type 1 (MEN1). Among those, tumors developed in upper gastrointestinal tract, thymus and bronchus have historically been called "carcinoid tumor". Occurrence of "carcinoid tumor" in other region is very rare and molecular pathogenesis of such tumors is unknown. We have experienced a patient with MEN1 who have developed an "ectopic" retroperitoneal neuroendocrine tumor. Genetic analysis of the MEN1 gene in tumor cells revealed a somatic mutation in exon 9 as well as a germline mutation in exon 10. Allele-specific amplification followed by sequence analysis revealed these two mutations exist on the different allele, indicating both alleles are functionally inactivated. Immunohistochemical staining with an anti-menin antibody revealed that wild-type menin is not expressed in tumor cells. Expression of p27(Kip1) protein is not observed in tumor cells, either. These results confirmed the inactivation of the MEN1 gene as a genetic cause of an ectopically developed neuroendocrine tumor in a patient with MEN1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564705     DOI: 10.1507/endocrj.k09e-126

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  1 in total

1.  Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report.

Authors:  Jasmine Shell; Dhaval Patel; Astin Powers; Martha Quezado; Keith Killian; Paul Meltzer; Jack Zhu; Apostolos Gaitanidis; Fatima Karzai; Vladimir Neychev; Patience Green; Electron Kebebew
Journal:  J Endocr Soc       Date:  2017-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.